Poly Medicure Limited

NSE POLYMED.NS

Poly Medicure Limited Revenue for the year ending March 31, 2024: USD 164.94 M

Poly Medicure Limited Revenue is USD 164.94 M for the year ending March 31, 2024, a 21.56% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Poly Medicure Limited Revenue for the year ending March 31, 2023 was USD 135.69 M, a 12.37% change year over year.
  • Poly Medicure Limited Revenue for the year ending March 31, 2022 was USD 120.75 M, a 14.08% change year over year.
  • Poly Medicure Limited Revenue for the year ending March 31, 2021 was USD 105.85 M, a 19.18% change year over year.
  • Poly Medicure Limited Revenue for the year ending March 31, 2020 was USD 88.81 M, a 4.43% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NSE: POLYMED.NS

Poly Medicure Limited

CEO Mr. Himanshu Baid
IPO Date Dec. 7, 2011
Location India
Headquarters 232B Okhla Industrial Estate
Employees 6,300
Sector Health Care
Industries
Description

Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.

Similar companies

THYROCARE.NS

Thyrocare Technologies Limited

USD 9.54

0.38%

VAIBHAVGBL.NS

Vaibhav Global Limited

USD 3.24

2.66%

SEQUENT.NS

Sequent Scientific Limited

USD 2.07

5.03%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 20.35

-1.23%

SHILPAMED.NS

Shilpa Medicare Limited

USD 9.00

6.34%

StockViz Staff

January 15, 2025

Any question? Send us an email